Oxford Drug Design

About:

Oxford Drug Design focuses on developing and delivering services and technologies in computer-aided drug discovery.

Website: http://www.oxforddrugdesign.com/

Top Investors: Meltwind Advisory, R42 Group, O2h Ventures, CARB-X, ACF Investors

Description:

InhibOx is a pioneer in the development and application of new technologies to drive drug discovery. Their multidisciplinary research team has brought together breakthroughs in computational chemistry, cheminformatics, mathematics, cloud computing and software-as-a-service (SaaS) delivery methods to create DrugFinder: the next generation drug discovery platform.